Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Director departure
Appointed director

AVENUE THERAPEUTICS, INC. (ATXI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2022 3 MacLean Alexandra (CEO) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
05/25/2022 3 Jin David (Int. PEO, Int. PFO, and COO) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
05/17/2022 3 Charles Faith L. (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
12/21/2021 3 Oltmans Curtis Gale (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
12/31/2019 3 InvaGen Pharmaceuticals, Inc. (10% Owner) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
08/01/2019 3 Ingram Elizabeth Garrett (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
04/30/2019 3 Moore Thomas Gregory (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
02/15/2019 3 Gogtay Jaideep Ashok (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
02/15/2019 3 Saxena Nishant (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
09/11/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
09/06/2017 3 Reines Scott (Interim Chief Medical Officer) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
08/23/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
08/22/2017 3 Vazzano Joseph Walter (VP Finance & Corp. Controller) has filed a Form 3 on AVENUE THERAPEUTICS, INC.
08/18/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
08/18/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
08/18/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
08/18/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
08/18/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
08/18/2017 3 SAMAD AKHTAR (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy